The Denver-based 10th U.S. Circuit Court of Appeals ruled that under
last year's Supreme Court's decision, jurors were wrongly instructed
on how to determine whether Shakeel Kahn knowingly prescribed
powerful drugs in an illegal manner.
He was at the center of a Supreme Court ruling in January 2022 that
raised the bar for what prosecutors must prove to secure convictions
of doctors accused of fueling the U.S. opioid crisis by turning
their medical practices into "pill mills."
Kahn's lawyer, Beau Brindley, said in a statement Friday's decision
"should pave the way to finally ending the practice of unfairly
scapegoating doctors for an opiate crisis for which they were never
responsible."
Kahn, 56, has been serving a 25-year prison sentence after a jury in
Wyoming in 2019 found him guilty of unlawfully distributing
prescription medications, operating a continuing criminal enterprise
and other charges.
Prosecutors said Kahn from 2011 to 2016 prescribed powerful pain
drugs to people in Arizona and Wyoming in exchange for money after
performing perfunctory or no examinations. They included one woman
who died of an oxycodone overdose.
At trial, Kahn did not contest that patients abused their
medications but disputed what his intent was in prescribing them
drugs, asserting he had a "good faith" reason to believe his
prescriptions were valid.
He took his case to the Supreme Court, which held that prosecutors
have to prove that doctors knew they illegally prescribed drugs in
violation of the federal Controlled Substances Act.
The justices left to the three-judge 10th Circuit panel to decide
whether jurors were properly instructed in Kahn's case under that
standard.
U.S. Circuit Judge Mary Beck Briscoe wrote that they were not,
saying the instructions "effectively lowered the government’s burden
to showing only that Dr. Kahn’s behavior was objectively
unauthorized - not that Dr. Kahn intended to act without
authorization."
(Reporting by Nate Raymond in Boston; Editing by Bill Berkrot)
[© 2023 Thomson Reuters. All rights
reserved.] Copyright 2022 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|
|